Compare
Pit 2–4 stocks against each other: U-Score, pillars, fundamentals, and normalized price history. Same universe, same methodology, one view.
| Metric | SAROJA Saroja Pharma Industries India Ltd. Pharma · SME | LASA Lasa Supergenerics Limited Pharma · Small | INFINIUM Infinium Pharmachem Ltd. Pharma · SME | ARVEE Arvee Laboratories (India) Limited Pharma · Small |
|---|---|---|---|---|
| Final Score | 49 | 5 | 49 | 21 |
| Verdict | FAIR VALUE | OVERVALUED | FAIR VALUE | OVERVALUED |
| Style | Deep Value | Distress Watch | Financial Turnaround | OVERVALUED |
| Piotroski | 6/9 | 2/9 | 8/9 | 5/9 |
| Valuation | 30/30 | 5/30 | 10/30 | 0/30 |
| Growth | 15/25 | 0/25 | 16/25 | 11/25 |
| Quality | 0/20 | 0/20 | 0/20 | 0/20 |
| Balance Sheet | 7/15 | 5/15 | 12/15 | 11/15 |
| Cash Flow | 1/10 | 3/10 | 8/10 | 3/10 |
| Price | ₹33.95 | ₹7.61 | ₹206.75 | ₹163.57 |
| P/E | 8.43 | — | 26.20 | 69.60 |
| P/B | 0.79 | 0.78 | 2.63 | 5.21 |
| ROE | 9.83% | -19.60% | 10.50% | 7.78% |
| ROCE | 13.00% | -18.20% | 13.10% | 7.92% |
| Debt / Equity | 0.83 | 0.20 | 0.00 | 0.03 |
| FCF Yield | — | — | 8.49% | 0.22% |
| Dividend Y | — | — | — | — |
| Altman Z | 2.91 | 1.73 | 6.12 | 7.99 |
| Promoter % | 73.02% | 53.65% | 64.91% | 73.50% |
| Mkt Cap (₹Cr) | 13.60 | 38.20 | 318.00 | 176.00 |
| Graham # | ₹62.44 | — | ₹116.77 | ₹39.86 |
| Fair PE | 42.0 | 1.3 | 42.0 | 42.0 |
| MoS % | +80.0% | — | +36.9% | -69.3% |
Normalized price (3-year, indexed to 100)
Higher line = better relative performance from startSAROJA86
LASA27
INFINIUM83
ARVEE96